Status:
UNKNOWN
Blood Ozonization in Patients With SARS-CoV-2 Respiratory Failure
Lead Sponsor:
Azienda Sanitaria-Universitaria Integrata di Udine
Collaborating Sponsors:
Fondazione Toscana Gabriele Monasterio
Policlinico Militare, Roma - Italy
Conditions:
SARS-CoV-2 Respiratory Failure
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
Aim. The emerging outbreak of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to spread worldwide. Beside the prescription of s...
Detailed Description
Recruitment Details. The investigator enrolled, in the study, subjects with COVID-19 modest to moderate respiratory insufficiency (SIMEU clinical phenotypes 2-4) thus cared in an infectious disease w...
Eligibility Criteria
Inclusion
- Male and no pregnant female patients 18 years of age or older were eligible if they had a diagnostic specimen that was positive on RT-PCR, had pneumonia confirmed by chest imaging and gave their informed consent to participate at the study
Exclusion
- Exclusion criteria were pregnancy, G6PHD (glucose 6 phosphate dehydrogenase) deficiency, concomitant serious disease and failure to obtain informed consent.
Key Trial Info
Start Date :
April 8 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 8 2020
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04388514
Start Date
April 8 2020
End Date
October 8 2020
Last Update
May 14 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dott. Amato De Monte
Udine, Italy